Author:
Hellstr�m J�rgen,Rudholm Niklas
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference12 articles.
1. Ganguli R (2002) Rationale and strategies for switching antipsychotics. Am J Health Syst Pharm 59:522?526
2. Goldstein JM, Cantillion M (1998) Safety of switching to quetiapine furmarate. Presented at the 151th Annual Meeting of the American Psychiatric Association. Toronto, Canada, 30 May 30?4 June
3. Kinon BJ, Basson BR, Gilmore JA, Malcolm S, Stauffer VL (2000) Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine. J Clin Psychiatry 61:833?840
4. Hartley K, Lavers RJ, Maynard AK (1986) Regulation and development times in the UK pharmaceutical industry. Scott J Polit Econ 33:355?369
5. Andersson F, Hertzman P (1993) Effective patent life of drugs in Sweden?a comparison with international studies. Manag Dec Econ 14:53?63
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献